BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9469277)

  • 1. Weekly nuchal translucency measurements in normal fetuses.
    Pajkrt E; de Graaf IM; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Obstet Gynecol; 1998 Feb; 91(2):208-11. PubMed ID: 9469277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuchal translucency measurement in normal fetuses.
    Pajkrt E; Bilardo CM; Van Lith JM; Mol BW; Bleker OP
    Obstet Gynecol; 1995 Dec; 86(6):994-7. PubMed ID: 7501355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac.
    Bekker MN; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM
    Obstet Gynecol; 2006 Oct; 108(4):846-53. PubMed ID: 17012445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia.
    Sebire NJ; Snijders RJ; Davenport M; Greenough A; Nicolaides KH
    Obstet Gynecol; 1997 Dec; 90(6):943-6. PubMed ID: 9397108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of nuchal cord on nuchal translucency measurement at 10-14 weeks.
    Schaefer M; Laurichesse-Delmas H; Ville Y
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):271-3. PubMed ID: 9618851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuchal translucency measurements: frequency distribution and changes with gestation in a general population.
    Braithwaite JM; Morris RW; Economides DL
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1201-4. PubMed ID: 8968236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of fetal position on nuchal translucency thickness.
    de Graaf IM; Müller MA; van Zuylen-Vié AA; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 2000 Jun; 15(6):520-2. PubMed ID: 11005121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
    Lam YH; Tang MH; Lee CP; Tse HY
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation.
    Brady AF; Pandya PP; Yuksel B; Greenough A; Patton MA; Nicolaides KH
    J Med Genet; 1998 Mar; 35(3):222-4. PubMed ID: 9541107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuchal translucency thickness and outcome in chromosome translocation diagnosed in the first trimester.
    Sepulveda W; Be C; Youlton R; Carstens E; Reyes M
    Prenat Diagn; 2001 Sep; 21(9):726-8. PubMed ID: 11559907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disappearance of enlarged nuchal translucency before 14 weeks' gestation: relationship with chromosomal abnormalities and pregnancy outcome.
    Müller MA; Pajkrt E; Bleker OP; Bonsel GJ; Bilardo CM
    Ultrasound Obstet Gynecol; 2004 Aug; 24(2):169-74. PubMed ID: 15287055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21.
    Hyett JA; Moscoso G; Nicolaides KH
    Am J Obstet Gynecol; 1995 May; 172(5):1411-3. PubMed ID: 7755046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
    Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester fetal nuchal translucency thickness and risk for trisomies.
    Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
    Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between increased nuchal translucency and second trimester cardiac echogenic foci.
    Prefumo F; Presti F; Thilaganathan B; Carvalho JS
    Obstet Gynecol; 2003 May; 101(5 Pt 1):899-904. PubMed ID: 12738147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.